Typhoid Antibody Testing Market Report 2026

The typhoid antibody testing market size has grown strongly in recent years. It will grow from $8.45 billion in 2025 to $9.1 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increasing prevalence of typhoid fever in endemic regions, expansion of public health screening programs, wider availability of serological testing methods, growth of diagnostic laboratory networks, rising awareness of infectious disease management.

The typhoid antibody testing market size is expected to see strong growth in the next few years. It will grow to $11.87 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing demand for rapid and accurate diagnostics, expansion of decentralized testing facilities, rising investments in advanced immunoassay technologies, growing focus on outbreak preparedness, increasing adoption of digital laboratory systems. Major trends in the forecast period include increasing adoption of rapid diagnostic test kits, rising demand for point-of-care typhoid testing, growing use of elisa-based assays, expansion of laboratory automation in diagnostics, enhanced focus on early disease detection.

The increasing prevalence of waterborne diseases is expected to drive the growth of the typhoid antibody testing market going forward. Waterborne diseases are illnesses caused by pathogenic microorganisms transmitted through contaminated water. Factors such as poor sanitation and hygiene, limited access to clean drinking water, rapid urbanization, climate change, and agricultural runoff contribute to the rise in waterborne diseases. Typhoid antibody testing supports this trend by enabling early diagnosis, confirmation, and monitoring of treatment effectiveness, helping identify carriers of typhoid fever and facilitating preventive measures against waterborne infections. For example, in May 2023, according to the Coalition Against Typhoid, a US-based organization focused on preventing typhoid and invasive salmonellosis, the Philippines reported 4,440 typhoid cases from January 1 to April 15, 2023, representing a 77% increase compared to the same period in 2022. Therefore, the growth of waterborne diseases is fueling demand for typhoid antibody testing.

Key companies in the typhoid antibody testing market are concentrating on developing advanced solutions, such as molecular diagnostic tests, to improve the accuracy and speed of typhoid fever diagnosis. Molecular diagnostic tests provide high sensitivity and specificity, enabling precise and rapid detection of pathogens like Salmonella Typhi. For instance, in April 2023, Vanguard Diagnostics, an India-based diagnostic reagent developer, launched the VANSCAN Typhoid RT-PCR test, a molecular diagnostic test utilizing its patented technology. This test is designed to detect and diagnose typhoid fever through real-time PCR (RT-PCR), offering greater accuracy and sensitivity compared to traditional serological tests. The VANSCAN Typhoid RT-PCR test represents a significant advancement in typhoid diagnostics, setting a new benchmark for early, reliable, and accurate disease detection both in India and globally.

In January 2023, SD Biosensor, Inc., a South Korea-based healthcare technology company specializing in in-vitro diagnostics, and SJL Partners LLC, a South Korea-based private equity firm, acquired Meridian Bioscience, Inc. for approximately $1.53 billion. Through this acquisition, the companies aim to strengthen their presence in the U.S. in-vitro diagnostics market by combining their manufacturing and R&D capabilities with Meridian’s U.S. distribution network and regulatory expertise. Meridian Bioscience, Inc., a US-based life sciences company, provides typhoid antibody testing through its rapid immunoassay product, TruQuick Typhoid.

Major companies operating in the typhoid antibody testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Sekisui Diagnostics, CTK Biotech Inc., Creative Diagnostics, Fortress Diagnostics Ltd., CerTest Biotec S.L, InBios International Inc., J. Mitra & Co. Pvt. Ltd, AccuBioTech Co. Ltd, Vanguard Diagnostics Pvt. Ltd., Suburban Diagnostics India Private Limited, Biorex Diagnostics, Genebio Healthcare Private Limited, ICT Diagnostics.

Asia-Pacific was the largest region in the typhoid antibody testing market in 2025. The regions covered in the typhoid antibody testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the typhoid antibody testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the typhoid antibody testing market by increasing costs of imported reagents, assay kits, laboratory consumables, diagnostic instruments, and electronic components used in testing platforms. Healthcare providers in Asia-Pacific, Africa, and Latin America are most affected due to reliance on imported diagnostics, while North America and Europe face higher procurement costs for advanced testing equipment. These tariffs are increasing testing expenses and affecting accessibility in low-resource settings. However, they are also encouraging local production of test kits, regional reagent manufacturing, and capacity building in domestic diagnostic industries.

The typhoid antibody testing market research report is one of a series of new reports that provides typhoid antibody testing market statistics, including typhoid antibody testing industry global market size, regional shares, competitors with a typhoid antibody testing market share, detailed typhoid antibody testing market segments, market trends and opportunities, and any further data you may need to thrive in the typhoid antibody testing industry. This typhoid antibody testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Typhoid antibody testing is a diagnostic method aimed at detecting antibodies against Salmonella enterica serotype Typhi, the bacterium that causes typhoid fever. The main purpose of typhoid antibody testing is to diagnose typhoid fever by identifying the immune response (antibodies) to Salmonella Typhi. This testing supports timely and accurate diagnosis, allowing for appropriate treatment and disease management.

The primary types of products in the typhoid antibody testing market include rapid serological tests, hemagglutination and co-agglutination, counter immunoelectrophoresis, the Typhidot test, and the Widal test. Rapid serological tests are diagnostic tools used to quickly identify the presence of antibodies or antigens in a patient’s blood sample. The tests also cover various types of paratyphi, including Paratyphi A, Paratyphi B, and Paratyphi C. They are utilized by different end-users, such as hospitals, serological testing centers, clinics, diagnostic centers, and others.

The typhoid antibody testing market consists of sales of immunochromatographic tests, western blot, and typhoid test strips. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.